Kinepolis Group NV/ BE0974274061 /
24.06.2024 9:14:00 | Изменение -0.100 | Объем сделки | Бид9:14:05 | Предложение9:14:06 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
36.000EUR | -0.28% | 959 Оборот: 34,607.300 |
35.900Величина цены спроса: 181 | 36.000Величина цены предложения: 110 | 981.04 млнEUR | 1.53% | 17.24 |
GlobeNewswire
9:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
8:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
7:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница